CRISPR Could Eliminate Human Pain

Scientists have identified a string of genetic code that functions as a volume knob for human suffering, and pharmaceutical firms are working to mimic the effects.

Painless Index / Image: Alyssa Foote
Painless Index / Image: Alyssa Foote

A recent Wired article discussed the concept of gene editing to eliminate pain. There’s a rare group of people who experience pain insensitivity, and their DNA could unlock the key to eliminating not just pain, but also anxiety from the human condition. However, the idea raises ethical issues. If a person is unable to experience pain and anxiety, does it affect their moral compass? Could gene editing be used to create super-soldiers?

While it’s certainly unpleasant, the human body evolved to feel pain as a way to notify a person that something is wrong with their body. One reason pioneers in gene-based pain therapy aren’t using CRISPR yet is that it’s permanent. Rather, companies are focusing on treating pain by engineering receptors in people’s sensory neurons that can be controlled by a small molecule drug in a virus. A one-time injection delivers instructions for creating a “tunable on/off switch.” This means that when a patient feels pain, they can take the drug to shut down pain perception without full-body side effects of risk of addiction.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report